Moderate riskFDA DrugClass II

Shoolin Pharma Chem tadalafil USP powder recalled for CGMP manufacturing deviations

The FDA identified current good manufacturing practice (CGMP) deviations during an inspection of Shoolin Pharma Chem LLP's facility in India. The company manufactures tadalafil USP powder (active pharmaceutical ingredient) intended for prescription compounding use. One batch (TLF2506001, expiring May 31, 2028) totaling 20 kg was distributed nationwide in the USA.

From the FDA notice · Read the official notice ↗

What to do

  1. If you are a licensed pharmacy or compounding facility that received this batch, quarantine it immediately and do not use it.
  2. Contact Shoolin Pharma Chem LLP or your supplier for instructions on return or disposal.
  3. Verify any compounded medications made from this batch and consult with the prescribing physician if concerned.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
TADALAFIL USP, 0.500 KG, 0.500KG(500gm)-bag, Rx only, "For Prescription Compounding Only", Shoolin Pharma Chem LLP, Block/Survey no 408, B/H Ratnamani Tubes, Near Maruti Inox, Indrad, Kadi, Mahesania, Gujarat, 382715, India, (CAS NO 171596-29-5), NDC 85702-002-04.
Sold in
Nationwide
Made for
All ages (0 months and older)

This recall covers 5 products — see all of them.

Details

Units affected
20 KG, 40 X 0.500KG(500gm) bags
Illnesses reported
None reported
Manufactured in
408 B/H Ratnamani Tubes, Block/Survey No; Nr Maruti Inox, Kadi, India
Classification
Class II
Recall number
D-0761-2026

In the FDA's words

Description
TADALAFIL USP, 0.500 KG, 0.500KG(500gm)-bag, Rx only, "For Prescription Compounding Only", Shoolin Pharma Chem LLP, Block/Survey no 408, B/H Ratnamani Tubes, Near Maruti Inox, Indrad, Kadi, Mahesania, Gujarat, 382715, India, (CAS NO 171596-29-5), NDC 85702-002-04. CGMP Deviations:Noted during FDA inspection Batch TLF2506001, Date of Expiry: May 31, 2028. Distribution: Distributed Nationwide in the USA Affected quantity: 20 KG, 40 X 0.500KG(500gm) bags
Hazard
CGMP Deviations:Noted during FDA inspection

5 products in this recall

Shoolin Pharma sildenafil and tadalafil powders recalled for manufacturing violations

Shoolin Pharma Chem LLP is recalling five bulk powder products, sildenafil citrate and tadalafil in 100-gram, 500-gram, and 1-kilogram sizes, sold for prescription compounding only. The recall was triggered by manufacturing practice (CGMP) deviations found during an FDA inspection, and no injuries have been reported. The products were distributed nationwide.

The agency lists each product separately. Check every one you might have.

Related topics

OtherDrugsSold nationwideMore from FDA Drug